Wordt geladen...
Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
Chimeric antigen receptor (CAR) T cell therapy has shown remarkable responses in B cell malignancies. However, many patients suffer from limited response and tumor relapse due to lack of persisting CAR T cells and immune escape. These clinical challenges have compromised the long-term efficacy of CA...
Bewaard in:
| Gepubliceerd in: | Leukemia |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680719/ https://ncbi.nlm.nih.gov/pubmed/32447345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0874-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|